These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9083517)

  • 41. Detection of the bcr/abl gene in bone marrow macrophages in CML and alterations during interferon therapy--a fluorescence in situ hybridization study on trephine biopsies.
    Thiele J; Schmitz B; Fuchs R; Kvasnicka HM; Lorenzen J; Fischer R
    J Pathol; 1998 Nov; 186(3):331-5. PubMed ID: 10211125
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Phenotype of blasts in chronic myeloid leukemia in blastic phase-Analysis of bone marrow trephine biopsies and correlation with cytogenetics.
    Reid AG; De Melo VA; Elderfield K; Clark I; Marin D; Apperley J; Naresh KN
    Leuk Res; 2009 Mar; 33(3):418-25. PubMed ID: 18760473
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mixed chimerism of the resident macrophage population after allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Wickenhauser C; Thiele J; Pérez F; Varus E; Stoffel MS; Kvasnicka HM; Beelen DW; Schaefer UW
    Transplantation; 2002 Jan; 73(1):104-11. PubMed ID: 11792988
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The impact of megakaryocyte proliferation of the evolution of myelofibrosis. Histological follow-up study in 186 patients with chronic myeloid leukaemia.
    Buhr T; Choritz H; Georgii A
    Virchows Arch A Pathol Anat Histopathol; 1992; 420(6):473-8. PubMed ID: 1609507
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Overexpression of Shp-2 is associated with the unlimited growth and apoptosis resistance of p210 bcr-abl-mediated chronic myeloid leukemia].
    Zhu XZ; Yu YZ; Fang YM; Liang Y; Lü QH; Xu RZ
    Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(27):1903-6. PubMed ID: 16255985
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Alterations in the bone marrow microenvironment may elicit defective hematopoiesis: a comparison of aplastic anemia, chronic myeloid leukemia, and normal bone marrow.
    Park M; Park CJ; Cho YW; Jang S; Lee JH; Lee JH; Lee KH; Lee YH
    Exp Hematol; 2017 Jan; 45():56-63. PubMed ID: 27693387
    [TBL] [Abstract][Full Text] [Related]  

  • 47. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
    Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
    Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Early reduction of BCR-ABL mRNA transcript levels predicts cytogenetic response in chronic phase CML patients treated with imatinib after failure of interferon alpha.
    Merx K; Müller MC; Kreil S; Lahaye T; Paschka P; Schoch C; Weisser A; Kuhn C; Berger U; Gschaidmeier H; Hehlmann R; Hochhaus A
    Leukemia; 2002 Sep; 16(9):1579-83. PubMed ID: 12200666
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Potential of bone marrow biopsy in chronic myeloproliferative disorders (MPD).
    Bartl R; Frisch B; Wilmanns W
    Eur J Haematol; 1993 Jan; 50(1):41-52. PubMed ID: 8436214
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Abnormal expression of N-CAM (CD56) adhesion molecule on myeloid and progenitor cells from chronic myeloid leukemia.
    Lanza F; Bi S; Castoldi G; Goldman JM
    Leukemia; 1993 Oct; 7(10):1570-5. PubMed ID: 7692192
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Philadelphia chromosome-negative chronic myeloid leukaemia: a report of 14 new cases.
    Costello R; Lafage M; Toiron Y; Brunel V; Sainty D; Arnoulet C; Mozziconacci MJ; Bouabdallah R; Gastaut JA; Maraninchi D
    Br J Haematol; 1995 Jun; 90(2):346-52. PubMed ID: 7794755
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Bone marrow histology. 3: Value of bone marrow core biopsy in acute leukaemia, myelodysplastic syndromes, and chronic myeloid leukaemia.
    Winfield DA; Polacarz SV
    J Clin Pathol; 1992 Oct; 45(10):855-9. PubMed ID: 1430254
    [No Abstract]   [Full Text] [Related]  

  • 53. A histomorphometric analysis of trephine biopsies of bone marrow from 65 patients with chronic myeloid leukemia. Classification of patients into subgroups with different survival patterns.
    Thiele J; Wienhold S; Zankovich R; Fischer R
    Anal Quant Cytol Histol; 1990 Apr; 12(2):103-16. PubMed ID: 2350386
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A comparison of the sensitivity of blood and bone marrow for the detection of minimal residual disease in chronic myeloid leukaemia.
    Lin F; Goldman JM; Cross NC
    Br J Haematol; 1994 Mar; 86(3):683-5. PubMed ID: 8043457
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Five year leukaemia-free survival of 72% and 77% for early stage acute and chronic myeloid leukaemia treated by HLA-identical sibling bone marrow transplantation.
    Atkinson K; Downs K; Dodds A; Concannon A; Milliken S
    Aust N Z J Med; 1996 Feb; 26(1):54-8. PubMed ID: 8775529
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Features of chronic myeloid leukemia at diagnosis. Study of a series of 134 cases].
    Jonte F; Barez A; Soto I; Rayón C; Carrera D; Coma A; Pérez Llanderal J; Arribas M
    Sangre (Barc); 1992 Oct; 37(5):345-50. PubMed ID: 1293773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G; Roy DC; Gonin R; Alyea EP; Bélanger R; Gyger M; Perreault C; Bonny Y; Lerra I; Murray C
    J Clin Oncol; 1995 Jul; 13(7):1704-13. PubMed ID: 7602361
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Prognostic significance of hepatocyte growth factor and microvessel bone marrow density in patients with chronic myeloid leukaemia.
    Zhelyazkova AG; Tonchev AB; Kolova P; Ivanova L; Gercheva L
    Scand J Clin Lab Invest; 2008; 68(6):492-500. PubMed ID: 18609087
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Persistence of bcr-abl mRNA-expressing cells in long-term cultures established from chronic myeloid leukemic bone marrow or blood.
    Pasternak G; Pasternak L
    Ann Hematol; 1994 Jan; 68(1):9-14. PubMed ID: 8110881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Bone marrow with gelatinous transformation associated with residual disease in imatinib mesylate-treated chronic myelogenous leukaemia (CML).
    Thakral B; Higa B; Venkataraman G; Velankar MM
    Pathology; 2012 Jan; 44(1):59. PubMed ID: 22157697
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.